US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

15.02 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
News headline image
MindMed Reports Q2 2025 Financial Results and Business Updates
From Mind Medicine Inc.
Via Business Wire
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025
From Mind Medicine (MindMed) Inc.
Via Business Wire
News headline image
MindMed Announces New Employee Inducement Grants
From Mind Medicine (MindMed) Inc.
Via Business Wire
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
From FN Media Group LLC
Via GlobeNewswire
News headline image
MindMed Announces New Employee Inducement Grants
From Mind Medicine Inc.
Via Business Wire
News headline image
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
News headline image
Why Mind Medicine Gave Investors a Powerful Buzz in May ↗
Via The Motley Fool
Topics Law Enforcement
News headline image
MindMed to Participate in June Investor Conferences
From Mind Medicine Inc.
Via Business Wire
News headline image
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer
From Mind Medicine Inc.
Via Business Wire
News headline image
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors ↗
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more. 
Via Benzinga
Topics Government
News headline image
Why Mind Medicine Stock Vaulted More Than 8% Higher Today ↗
Via The Motley Fool
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday. 
Via Chartmill
News headline image
Agilysys, Amer Sports, X Financial And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
MindMed Announces New Employee Inducement Grants
From Mind Medicine Inc.
Via Business Wire
News headline image
MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference
From Mind Medicine (MindMed) Inc.
Via Business Wire
News headline image
MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates
From Mind Medicine Inc.
Via Business Wire
News headline image
MindMed to Report First Quarter 2025 Financial Results on May 8, 2025
From Mind Medicine (MindMed) Inc.
Via Business Wire
News headline image
MindMed Announces New Employee Inducement Grants
From Mind Medicine Inc.
Via Business Wire
News headline image
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
From Mind Medicine (MindMed) Inc.
Via Business Wire
News headline image
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
MindMed Announces New Employee Inducement Grants
From Mind Medicine Inc.
Via Business Wire
Study Finds That the Mental Wellbeing Effects of Psilocybin Vary by Race
Via Investor Brand Network
News headline image
MindMed Appoints Matt Wiley as Chief Commercial Officer
From Mind Medicine Inc.
Via Business Wire
News headline image
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
Mind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay Bullish ↗
The psychedelics treatment developer reported a net loss of $34.7 million for the quarter ended Dec. 31, 2024, widening from a $23.8 million loss a year earlier. 
Via Stocktwits
News headline image
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
From Mind Medicine Inc.
Via Business Wire
News headline image
MindMed to Present at Leerink’s Global Healthcare Conference 2025
From Mind Medicine Inc.
Via Business Wire
News headline image
Earnings Scheduled For March 6, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >